Emergent BioSolutions (EBS) Long-Term Debt Repayments (2011 - 2026)
Emergent BioSolutions' Long-Term Debt Repayments was -$81.9 million in Q3 2026, compared with $6.9 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Long-Term Debt Repayments (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' Long-Term Debt Repayments was $26.8 million through Sep 30, 2026, up 288.4% year-over-year; for FY2025, it was $108.7 million, down 45.2% from FY2024.
- Long-Term Debt Repayments shows a five-year compound annual growth rate of 50.5% (FY2020 to FY2025).
- In earlier years, Long-Term Debt Repayments was $198.2 million in FY2024 (+20.4%), $164.6 million in FY2023 (+387.0%), $33.8 million in FY2022 (-5.8%) and $35.9 million in FY2021 (+154.6%).
- The Q3 2026 figure marks the lowest quarterly Long-Term Debt Repayments in data going back to Q3 2011.
- The best year-over-year quarter for Long-Term Debt Repayments over five years was Q3 2022 (growth of 50.0%); the worst was Q2 2024 (a decline of 97.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | -81.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -81.90 Mn |
| Dec 31, 2025 | 101.80 Mn |
| Sep 30, 2025 | 6.90 Mn |
| Sep 30, 2024 | 190.30 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 148.40 Mn |
| Mar 31, 2023 | 8.40 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | 8.40 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 5.70 Mn |
| Mar 31, 2021 | 16.20 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Sep 30, 2020 | 2.80 Mn |
API Access
Emergent BioSolutions Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();